Related Experiment Video
Updated: Jul 18, 2026

Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
Risk factors associated with refractory peptic ulcers
A I Lanas1, B Remacha, F Esteva
1Servicio de Aparato Digestivo, Hospital Clínico Universitario de Zaragoza, Spain.
Nonsteroidal anti-inflammatory drug (NSAID) and analgesic abuse are key factors in refractory peptic ulcers. Helicobacter pylori infection is also significant, but some cases remain unexplained.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pharmacology
Background:
- Refractory peptic ulcers present a clinical challenge with undefined risk factors.
- Understanding these factors is crucial for effective patient management and treatment strategies.
Purpose of the Study:
- To identify risk factors associated with refractory peptic ulcers using a multivariate analysis.
- To differentiate between exogenous and intrinsic factors contributing to ulcer refractoriness.
Main Methods:
- A comparative study involving 60 refractory peptic ulcer patients and 54 nonrefractory controls.
- Assessment included clinical data, Helicobacter pylori status, gastric secretion, gastrin levels, and objective testing of nonsteroidal anti-inflammatory drug (NSAID) and analgesic use.
Main Results:
- Refractory patients exhibited longer ulcer history, earlier onset, more relapses, and higher smoking rates.
- NSAID-analgesic abuse was identified in 40% of refractory patients, with 43.7% of NSAID use being surreptitious.
- Multivariate analysis pinpointed NSAID/analgesic abuse and relapse frequency as significant factors.
Conclusions:
- Nonsteroidal anti-inflammatory drug (NSAID) and analgesic abuse is the primary exogenous risk factor for refractory peptic ulcers.
- Helicobacter pylori infection is an important intrinsic factor, though not universally present in refractory cases.
- A significant proportion of refractory peptic ulcers remain unexplained by NSAID use or H. pylori infection.
More Related Videos
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease II: Pathophysiology